MALAT1 and nasopharyngeal carcinoma: Results showed that levels of MALAT1 (Figure 1A), AFAP1-AS1 (Figure 1B) and AL359062 (Figure 1C) significantly increased in NPC patients compared to HC, CN, or EC (all with p < 0.001).